Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(64)
- Ack1(2)
- Axl(6)
- ALK(54)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(35)
- c-Kit(55)
- c-MET(82)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(225)
- EphB4(1)
- FAK(33)
- FGFR(94)
- FLT3(82)
- HER2(15)
- IGF1R(33)
- Insulin Receptor(42)
- IRAK(28)
- ITK(10)
- Lck(1)
- LRRK2(21)
- PDGFR(104)
- PTKs/RTKs(3)
- Pyk2(6)
- ROR(38)
- Spleen Tyrosine Kinase (Syk)(32)
- Src(95)
- Tie-2 (4)
- Trk(40)
- VEGFR(181)
- Discoidin Domain Receptor(15)
- DYRK(28)
- Ephrin Receptor(12)
- RET(28)
- ROS(14)
- TAM Receptor(28)
- IGFBR(1)
- Others(55)
- Cat.No. 产品名称 Information
-
GC13547
Dovitinib (TKI-258, CHIR-258)
多韦替尼; CHIR-258; TKI258
A multi-kinase inhibitor -
GC11759
Imatinib Mesylate (STI571)
甲磺酸伊马替尼; STI571 Mesylate; CGP-57148B Mesylate
An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit - GC16712 BMS-754807 Dual inhibitor of IGF-1R and InsR tyrosine kinases
-
GC17958
Linifanib (ABT-869)
利尼伐尼,ABT-869; AL-39324
A dual VEGFR and PDGFR family kinase inhibitor - GC15664 SGX-523 A potent inhibitor of c-Met
-
GC12729
PF-04217903
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇
A c-Met inhibitor - GC15494 WZ4002 A potent inhibitor of EGFR-T790M kinase activity
-
GC13697
AG-1024
Tyrphostin AG 1024
A selective inhibitor of IGF-1R -
GC13410
Masitinib (AB1010)
马赛替尼; AB1010
An inhibitor of c-Kit -
GC11089
SU11274
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺,PKI-SU11274
A potent, selective inhibitor of c-Met - GC11666 Ki8751 A potent, orally available VEGFR2 inhibitor
-
GC11733
PHA-665752
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷
A selective c-Met inhibitor -
GC14102
Genistein
染料木素; NPI 031L
染料木黄酮是一种异黄酮,属于类黄酮化合物,存在于多种植物中。 -
GC17773
BMS-536924
胰岛素样生长因子-1受体拮抗剂
A dual inhibitor of IGF-1R and IR -
GC13343
Bosutinib (SKI-606)
伯舒替尼,SKI-606
An inhibitor of Src and Abl kinases -
GC14683
Sunitinib malate
苹果酸舒尼替尼,SU 11248,SU11248,SU-11248,Sunitinib
A multi-kinase inhibitor -
GC17943
PD 173074
PD 173074,PD-173074
Inhibitor of tyrosine kinase activity of fibroblast growth factor receptors -
GC11705
Nintedanib (BIBF 1120)
尼达尼布,Vargatef
A VEGFR, FGFR, and PDGFR inhibitor -
GC16694
TAE684 (NVP-TAE684)
TAE 684
A selective ALK inhibitor -
GC13296
Afatinib(BIBW2992)
阿法替尼
A selective dual inhibitor of EGFR/HER2 -
GC16499
Sorafenib Tosylate
甲苯磺酸索拉非尼; Bay 43-9006 Tosylate
A multi-kinase inhibitor -
GC10344
PP 2 (AG 1879)
AGL 1879
A selective inhibitor of Src tyrosine kinases -
GC17990
PP 1
蛋白磷酸酯酶-1(抗原),AGL 1872; EI 275
Potent, selective Src family tyrosine kinase inhibitor -
GC12776
SKLB610
SKLB610; SKLB 610; SKLB-610
An inhibitor of VEGFR2 -
GC10111
Regorafenib
瑞戈非尼; BAY 73-4506
A multi-kinase inhibitor -
GC15600
Erlotinib Hydrochloride
盐酸埃罗替尼; CP-358774 hydrochloride; NSC 718781 hydrochloride; OSI-774 hydrochloride
An EGFR tyrosine kinase inhibitor -
GC14129
Nilotinib(AMN-107)
尼洛替尼; AMN107
Nilotinib(AMN-107)(尼洛替尼)是一种选择性口服酪氨酸激酶抑制剂,可抑制天然Bcr-Abl(WT p210)和突变型Bcr-Abl(E281K、E292K、F317L、M351T和F486S)的自磷酸化,IC50值分别为20、42、31、38、29和41nM。 -
GC16737
Gefitinib (ZD1839)
吉非替尼; ZD1839
吉非替尼(Gefitinib, ZD1839)是一种强效的表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI),IC50为0.033 µM,能选择性抑制表皮生长因子刺激的肿瘤细胞生长,IC50为0.054 µM,并能阻断表皮生长因子刺激的表皮生长因子受体(EGFR)在肿瘤细胞中的自身磷酸化。
-
GC13608
Lapatinib
拉帕替尼; GW572016; GW2016
A dual inhibitor of EGFR and ErbB2 -
GC14464
Vatalanib
瓦他拉尼碱,CGP-79787; PTK 787; ZK222584
A potent and selective VEGF receptor inhibitor -
GC16593
Lapatinib Ditosylate
二甲苯磺酸拉帕替尼; GW572016 ditosylate monohydrate; GW2016 ditosylate monohydrate
Lapatinib Ditosylate (GW572016 ditosylate monohydrate) 是有效的 ErbB-2 和 EGFR 酪氨酸激酶结构域抑制剂,对纯化的 EGFR 和 ErbB-2 的 IC50 值分别为 10.2 和 9.8 nM。 -
GC17033
Lestaurtinib
来他替尼; CEP-701; KT-5555
A potent JAK2 and PRK1 kinase inhibitor - GC11496 TLQP 21 TLQP 21 是一种 VGF 衍生肽,具有内分泌和内分泌特性,是一种有效的 G 蛋白偶联受体补体 3a 受体 1 (C3aR1) 激动剂(EC50:小鼠 TLQP 21\u003d10.3 μM;人 TLQP 21\u003d68.8 μM) .
-
GC12656
ZM323881
ZM 323881;ZM-323881
A potent and selective VEGFR2 inhibitor -
GC13102
XL228
N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺,XL-228;XL 228
A tyrosine kinase inhibitor -
GC11876
Vandetanib hydrochloride
Zactima hydrochloride; ZD6474 hydrochloride;ZD-6474 hydrochloride; ZD 6474 hydrochloride
A multi-kinase inhibitor -
GC10719
Toceranib
托西尼布; SU11654; PHA 291639E
A multi-targeted receptor tyrosine kinase inhibitor -
GC11622
TG 100801
4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚苯甲酸酯,TG100801;TG-100801
TG 100801 是一种前药,可通过在开发过程中的去酯化作用产生 TG 100572,以治疗年龄相关性黄斑变性。 TG 100572 是一种多靶点激酶抑制剂,可抑制受体酪氨酸激酶和 Src 激酶;对于 VEGFR1、VEGFR2、FGFR1、FGFR2、PDGFRβ、Fgr、Fyn、Hck、Lck、Lyn、Src、Yes , 分别。 -
GC15307
SU5416
司马沙尼; SU5416; Semaxanib
SU5416 是一种有效的小分子血管内皮生长因子受体 (VEGFR) 抑制剂。 -
GC14315
SU14813 maleate
5-[(Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-N-[(2S)-2-羟基-3-(4-吗啉基)丙基]-2,4-二甲基-1H-吡咯-3-甲酰胺马来酸盐,SU-14813 maleate;SU 14813 maleate
A dual VEGFR and PDGFR family kinase inhibitor -
GC11790
SU14813 double bond Z
SU-14813;SU 14813
Tyrosine kinase inhibitor -
GC14733
SU14813
SU-14813;SU 14813
A dual VEGFR and PDGFR family kinase inhibitor -
GC14660
SU 5402
2-[(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-4-甲基-1H-吡咯-3-丙酸,SU-5402; SU5402
An inhibitor of VEGFR2, FGFR1, and PDGFRβ -
GC12877
SR3335
ML-176;SR 3335;SR-3335;ML176;ML 176
A selective inverse agonist of RORα -
GC16392
SR1078
SR 1078;SR-1078
A selective RORα/RORγ agonist -
GC11455
Silvestrol
(1R,2R,3S,3AR,8BS)-6-[[(2S,3R,6R)-6-[(1R)-1,2-二羟基乙基]-3-甲氧基-1,4-二氧己环-2-基]氧基]-2,3,3A,8B-四氢-1,8B-二羟基-8-甲氧基-3A-(4-甲氧基苯基)-3-苯基-1H-环戊烯并[B]苯并呋喃-2-羧酸甲酯,(-)-Silvestrol
Silvestrol 是一种真核翻译起始因子 4A (eIF4A) 抑制剂,从 Agave americana Linn 中分离出来。Silvestrol 诱导自噬和半胱天冬酶介导的细胞凋亡。 -
GC12064
SB1317
14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯,TG02;SB 1317;TG 02;SB-1317;TG-02
A multi-kinase inhibitor -
GC14534
Regorafenib monohydrate
瑞格非尼一水合物,BAY 73-4506 monohydrate
A multi-kinase inhibitor -
GC14606
Regorafenib hydrochloride
瑞戈非尼盐酸盐; BAY 73-4506 hydrochloride
A multi-kinase inhibitor -
GC12857
R1530
5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓,R 1530;R-1530
A multi-kinase inhibitor